MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03613cam a22003618i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
14632082 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20250814151714.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
061113r20192011ii a b 00| 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9789387085176 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DNLM/DLC |
| Transcribing agency |
DLC |
| Description conventions |
rda |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.58 |
| Edition number |
22 |
| Item number |
N.B.C |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Nanjwade, Basavaraj K. |
| Relator term |
author. |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Clinical pharmacy and therapeutics / |
| Statement of responsibility, etc |
Basavaraj K. Nanjwade; Jigar M. Patel. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
First edition |
| 264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
New Delhi : |
| Name of publisher, distributor, etc |
CBS Publishers & Distributors ; |
| Date of publication, distribution, etc |
2011 |
| 264 #3 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
New Delhi : |
| Name of publisher, distributor, etc |
CBS Publishers & Distributors ; |
| Date of publication, distribution, etc |
2020. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
242 pages : |
| Other physical details |
illustration ; |
| Dimensions |
22 cm |
| 336 ## - CONTENT TYPE |
|---|
| Source |
rdacontent |
| Content type term |
text |
| 337 ## - MEDIA TYPE |
|---|
| Source |
rdamedia |
| Media type term |
unmediated |
| 338 ## - CARRIER TYPE |
|---|
| Source |
rdacarrier |
| Carrier type term |
volume |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Preface -- Chapter 1 Introduction to Clinical Pharmacy -- Introduction -- Aim of Clinical Pharmacy -- Basic components of Clinical Pharmacy-- Objectives of Clinical Pharmacy -- Scope of Clinical Pharmacy -- Role of Clinical Pharmacy services -- Review Questions -- Chapter 2 Basic concepts of Pharmacotherapy -- Introduction -- Clinical Pharmacokinetics -- Individualization of Drug therapy -- Special precautions in drug usage during infancy and in the elderly (pediatrics and Geriatrics).. 2.5 Drug usage in pregnancy and lactation-- Drug reactions.. 2.7 Drug interactions. 2.8 Interpretation of clinical Laboratory tests.. ............ Review Questions.. Chapter 3 Disorders of Organ systems and their Management Part A Cardiovascular diseases 3.1 Hypertension. 3.2 Congestive heart failure. 3.3 Angina.3.4 Acute myocardial Infarction... 3.5 Cardiac Arrhythmias.. Part B CNS Disorders 3.6 Epilepsy.. 3.7 Parkinsonism. 3.8 Schizophrenia depression. Review Questions. Chapter 4 Respiratory Diseases and Gastrointestinal D Part A Respiratory Disorders 4.1 Asthama -- Part B Gastrolntestinal Disorders 4.2 Peptic ulce . 4.3 Ulcerative Colitis. 4.4 Hepatitis. 4.5 Cirrhosis ..... Review questions. Chapter 5 Part A Endocrine Disorders S.1 Diabetes Mellitus... 5.2 Thyroid Disorders.. Part B Infectious Diseases 5.3 Tuberculosis.. 5.4 Urinary tract infection.. 5.5 Enteric infections.. Review questions. Chapter 6 Part A Hematopoietic Disorders 6.1 Anemia.. Part B Joint and connective tissue disorders 6.2 Rheumatic Disorders. 6.3 Hyperuricemia. 6.4 Gout. -- Part C Nooplastic divene 6.5 Acute Leukomias.. 6.6 HodgKin's disonse.. Review questions.. Chapter 7 Therapeutle Drog Monitoring(TDM) 7.1 Introduction.. 7.2 Criteria for Therapeutic Drug Monitoring. 7.3 Considerations for TDM. 7.4 TDM: Therapeutic and Toxic range.. Review questions ....... Chapter 8 Concept of Essential and Rational drug use 8.1 Introduction.. 8.2 The problem of irrational use of drugs.. 8.3 Assessing the problem of Irational use. 8.4 Quantitative Methods. 8.5 Qualitative Methods.. 8.6 Selected WHO/INRUD drug use indicators(WHO, 1993). 8.7 Overview of intervention strategies.. 8.8 WHO/INRUD 12 core interventions to promote more rational use of drugs Review questions.. References and Bibliography. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
A practical guide for the treatment of common diseases, this updated edition includes the very latest information. It covers the treatment of disease by drug therapy and uses case studies to illustrate the application of the principles discussed |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Chemotherapy. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmacology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Therapeutics. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmacy. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug Therapy. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmacology, Clinical. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Patel, Jigar M. |
| Relator term |
author. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Books |
| Source of classification or shelving scheme |
Dewey Decimal Classification |